Correlation Between Puradelta Lestari and Diagnos Laboratorium

Can any of the company-specific risk be diversified away by investing in both Puradelta Lestari and Diagnos Laboratorium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puradelta Lestari and Diagnos Laboratorium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Puradelta Lestari PT and Diagnos Laboratorium Utama, you can compare the effects of market volatilities on Puradelta Lestari and Diagnos Laboratorium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puradelta Lestari with a short position of Diagnos Laboratorium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puradelta Lestari and Diagnos Laboratorium.

Diversification Opportunities for Puradelta Lestari and Diagnos Laboratorium

0.49

Correlation Coefficient

Puradelta Lestari  Diagnos Laboratorium

Very weak diversification

The 3 months correlation between Puradelta and Diagnos is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Puradelta Lestari PT and Diagnos Laboratorium Utama in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diagnos Laboratorium and Puradelta Lestari is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puradelta Lestari PT are associated (or correlated) with Diagnos Laboratorium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diagnos Laboratorium has no effect on the direction of Puradelta Lestari i.e., Puradelta Lestari and Diagnos Laboratorium go up and down completely randomly.

Pair Corralation between Puradelta Lestari and Diagnos Laboratorium

Assuming the 90 days trading horizon Puradelta Lestari PT is expected to generate 0.21 times more return on investment than Diagnos Laboratorium. However, Puradelta Lestari PT is 4.71 times less risky than Diagnos Laboratorium. It trades about -0.1 of its potential returns per unit of risk. Diagnos Laboratorium Utama is currently generating about -0.11 per unit of risk. If you would invest  16,300  in Puradelta Lestari PT on September 14, 2024 and sell it today you would lose (800.00) from holding Puradelta Lestari PT or give up 4.91% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Puradelta Lestari PT  vs.  Diagnos Laboratorium Utama

Puradelta Lestari

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Puradelta Lestari PT has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking signals, Puradelta Lestari is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Diagnos Laboratorium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Diagnos Laboratorium Utama has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Puradelta Lestari and Diagnos Laboratorium

The main advantage of trading using opposite Puradelta Lestari and Diagnos Laboratorium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puradelta Lestari position performs unexpectedly, Diagnos Laboratorium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diagnos Laboratorium will offset losses from the drop in Diagnos Laboratorium's long position.

The idea behind Puradelta Lestari PT and Diagnos Laboratorium Utama pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.